Package 49884-158-02

{"route": ["ORAL"], "spl_id": "bf8637b9-79c5-42fc-8de0-b6209ad745f0", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "unii": ["9HW64Q8G6G"], "rxcui": ["977427", "977434", "977438", "2056895"], "spl_set_id": ["59cb86d5-8706-4619-b074-af253d3e0b68"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Par Health USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (49884-158-02)  / 10 TABLET in 1 BLISTER PACK (49884-158-52)", "package_ndc": "49884-158-02", "marketing_start_date": "20220331"}], "brand_name": "Everolimus", "product_id": "49884-158_bf8637b9-79c5-42fc-8de0-b6209ad745f0", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "49884-158", "generic_name": "Everolimus", "labeler_name": "Par Health USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": ".25 mg/1"}], "application_number": "ANDA205775", "marketing_category": "ANDA", "marketing_start_date": "20220331", "listing_expiration_date": "20261231"}